Navigation Links
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Date:3/24/2008

damaging the liver. BARACLUDE does not cure HBV or stop the spread of HBV to others. People should not take BARACLUDE if they are allergic to it or any of its ingredients. BARACLUDE has not been studied in children and is not recommended for anyone less than 16 years of age.

People taking BARACLUDE should tell their healthcare provider right away if they feel very weak or tired, have unusual muscle pain, have trouble breathing, have stomach pain with nausea and vomiting, feel cold -- especially in their arms and legs, feel dizzy or lightheaded, or have a fast or irregular heartbeat, as they may be signs of a serious condition called lactic acidosis (buildup of an acid in the blood). Lactic acidosis is a medical emergency and must be treated in the hospital. Some people who have taken medicines like BARACLUDE have developed serious liver problems called hepatotoxicity. This may occur with liver enlargement (hepatomegaly) and fat in the liver (steatosis).

People should call their healthcare provider right away if they get any of the following signs of liver problems: yellowing (jaundice) of the skin or the white part of the eyes, darkening of the urine, lightening in the color of bowel movements (stools), not feeling like eating food for several days or longer, feeling sick to the stomach (nausea), or having lower stomach pain. Lactic acidosis and hepatotoxicity have happened in some people taking medicines like BARACLUDE.

For people taking BARACLUDE who have or get HIV (the virus that can cause AIDS) and are not taking medicines for HIV at the same time, some HIV treatments that they may take in the future may be less likely to work. People are advised to get an HIV test before starting to take BARACLUDE and anytime that there is a chance they were exposed to HIV. BARACLUDE will not help HIV infection.

In some people, hepatitis B symptoms may get worse or become very serious when they stop taking BARACLUDE. People should not stop BARACLUDE
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
2. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
3. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
4. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
5. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
6. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
7. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
11. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Reportlinker.com announces that a ...alogue. ,, Pipettes & Pipettors - A Global...er.com/p0164373/Pipettes--Pipettors---A-Global-Mar..._medium=pr&utm_campaign=prnewswire ,, Pip...t of any research laboratory. Large-scale applicat...
(Date:11/20/2009)... Reportlinker.com announces that a ...alogue. ,, Global Markets for Assisted Reprodu...r.com/p0164742/Global-Markets-for-Assisted-Reprodu...utm_medium=pr&utm_campaign=prnewswire ,, ...e U.S., 15 Countries in Europe and Japan. This rep...
(Date:11/20/2009)...Newswire-FirstCall/ -- Biotel Inc. (OTC Bulletin B...r ended September 30, 2009 with net earnings of $1... $3,263,000. This compares to net earnings of $32...$3,168,000 for the first quarter of last year. ,... President and CEO Steve Springrose said: "Biotel ...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre 49149 1Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre 49149 2Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 1Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 2Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 3Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 1Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 2Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 3
...ces Deal for Vaccine Delivery System, NYON, Switze...metics Corporation announced today that the Compan... a non-human primate model.,Mucosal IgA antibodies...gainst infection by HIV. The data were presented b...c Officer in an,oral presentation, "Without Mucosa...
...rch 29, 2007 /PRNewswire-FirstCall/ -- Baxter,Inte...ta for its,adjuvant-free investigational pandemic ...se III clinical trial of the candidate,vaccine in .../II study indicated that Baxter,s H5N1 candidate,v...uces substantial,levels of cross immunity against ...
Other Medicine Technology:Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 2Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5
(Date:11/22/2009)...Smart, an innovative healthcare benefit solutions ...completed a recapitalization with Silver Point Cap... Silver Point Capital, L.P. is a private investmen...pitalization allows the Company to continue its gr... (PRWEB) November 22, 2009 --...
(Date:11/21/2009)... Tonight, in a partisan ...Reid,s version of the government takeover of healt...uded in this bill; like the public option, employe...ng for elective abortion, which is the most onerou... provides subsidies for private plans that cover e...
(Date:11/21/2009)... A regional initiative ...(river blindness) in the Americas has substantiall...years, as evidenced by a 31% decrease in the numbe...n in six endemic countries. Results were reported...Society of Tropical Medicine and Hygiene (ASTMH). ...
(Date:11/21/2009)...tive medical apparel company launches men,s lab co... San Clemente, Calif. (PRWEB) November 21, 2...l apparel, today announced the launch of its men,s... leading international trade fair for the medical ...ugurates its men,s collection with three varying l...
(Date:11/21/2009)...d Group ask whether there is a secret to ,alcohol ... London, UK (PRWEB) November 21, 20...three of the adult UK population drinking enough a...ted liver disease*, it is hardly a surprise that m...grammes and residential centres for help. However,...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
... Md., March 11 InforMedix Holdings,Inc. (OTC Bull...as engaged,Murdock Capital Partners to provide Cap...ock Capital, based in New York City, is a 16 year ...apital,merger and acquisitions, exchange listings,...
...arent company, Medical Mutual of Ohio to benefit f... improved customer service, CLEVELAND, March 11 ...and process management software solution, has been... Mutual,of Ohio (MMO)., (Logo: http://www.newsco...
... of LISTERINE(R) Products Launch New Children,s Fl...ourage Healthier Habits and Establish ...S, N.J., March 11 Parents confess that kids,can b...egyOne and Harris Interactive, excuses range from ...
...n of US Infrastructure Completes Build of EUSA,s T...on Platform US$22.6 Million Acquisition Expan...50 Million to Fund Acquisition and Other Investmen...ology, pain control and critical care, today annou...
...lif., March 11 LifeMasters Supported,SelfCare, In...ent programs,and services, today announced it has ...vestors including VantagePoint Venture Partners, o...execute on,its strategic growth initiatives and ex...
...ss Attorney Weight Loss Coaching and Present Ideas...r Lifestyle, WASHINGTON, March 10 Leventhal Weig...utive weight loss coaching,service for attorneys b....C. office of Nixon Peabody LLP this Wednesday, Ma...
Other Medicine News:Health News:InforMedix Retains Murdock Capital Partners 2Health News:InforMedix Retains Murdock Capital Partners 3Health News:InforMedix Retains Murdock Capital Partners 4Health News:Antares Management Solutions Selects Hyland Software's OnBase 2Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 2Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 3Health News:The Disappearing Toothbrush: Survey Reveals Kids' Top Excuses to Avoid Brushing 4Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 2Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 3Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 4Health News:EUSA Pharma to Acquire US Specialty Oncology Company Cytogen 5Health News:LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors 2Health News:LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors 3Health News:Mark Leventhal To Address Nixon Peabody LLP 2
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: